Advertisement
U.S. Markets closed

CBD Life Sciences Inc. (CBDL)

OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
0.00050.0000 (0.00%)
At close: 01:20PM EST

CBD Life Sciences Inc.

10855 N 116th Street
Suite 115
Scottsdale, AZ 85259
United States
480 410 6780
https://lbcbioscienceinc.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 3

Key Executives

NameTitlePayExercisedYear Born
Ms. Lisa Anne NelsonCEO, President, CFO, Secretary, Treasurer & Director120kN/A1967
Mr. Matthew McGeeChief Marketing Officer60kN/A1999
Ms. Brianna NelsonChief Product Developer & DirectorN/AN/A1997
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, coffee, wine, skincare line, tablets, and a line of pet products. The company is based in Scottsdale, Arizona.

Corporate Governance

CBD Life Sciences Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.